Suraksha Diagnostic Ltd share price inched up 2.28% to Rs 350.4 after the company's net profit rose by 16.34% to Rs 14.95 crore, while revenue from operations edged up 13.03% to Rs 99.07 crore in Q2FY27 over Q2FY26.

The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 84532.86 crore, heading higher 10.73%. It has marginally improved by 0.20% over last one week and eased lower by 2.01% in last one month while the market capitalization of Suraksha Diagnostic Ltd has improved by 5.19% and 14.27% in the same period respectively.

Profit before tax (PBT) of Suraksha Diagnostic Ltd stood at Rs 18.87 crore in Q2 FY27, surging by 56.60% year-on-year, and improving 14.16% quarter-on-quarter. EBITDA came in at Rs 33 crore, rallying 43.25% YoY and climbing 13.53% sequentially.

Total expenses went up by 12.24% to Rs 76.87 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 11.25 crore, advancing by 12.50% YoY, while employee benefits expense was at Rs 14.96 crore, inching up 3.82% YoY.

For FY26, revenue from operations witnessed a strong growth of 23.13% to Rs 310.41 crore, while net profit saw a mild growth of 1.36% to Rs 31.4 crore, compared to previous FY. EBITDA surged by 8254% to Rs 92.24 crore, and PBT saw a minor gain of 7.61% to Rs 44.56 crore compared to previous FY.

The company's consolidated net cash flow from operating activities stood at Rs 81.83 crore in FY26, as against Rs 63.36 crore in FY25.

Suraksha Diagnostic Ltd soared by 8.35% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.91% during the same period.